News

HAYWARD, Calif., October 12, 2021 – Potrero Medical, innovator of the Accuryn Monitoring System, a sensory integrated foley catheter that provides real-time, actionable information to health care providers so they can take steps to prevent the progression of critical conditions such as acute kidney injury (AKI), announced that Rebecca Lin has been promoted to the […]

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, recently presented data from the company’s prospective, multi-center, randomized, crossover study (NILE – NCT04908254) comparing Dayspring®, the company’s active compression treatment for lymphedema, to a traditional pneumatic compression pump. In the trial, study

DENVER–(BUSINESS WIRE)– Koya Medical, a transformative healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, and Essity, a leading global hygiene and health company that has as history of supporting space travel through the manufacturing of compression suits for astronauts, are sponsoring a forum to highlight the importance of venous and lymphatic

Combining Machine Learning with Next-Generation Sequencing creates Dermal Intelligence™: actionable information for payers, providers and patients to improve health outcomes and reduce healthcare spending. (SAN DIEGO, CA – October 5, 2021) Mindera Corporation, developers of the groundbreaking Mind.Px™ – the first realization of truly personalized medicine in psoriasis – has changed its name to Mindera

HAYWARD, Calif., October 05, 2021 – Potrero Medical, innovator of the Accuryn Monitoring System, a sensory integrated foley catheter that provides real-time, actionable information to health care providers so they can take steps to prevent critical conditions such as acute kidney injury (AKI), announced that Vanessa Moll, MD, PhD, FCCM, FASA has joined the executive leadership

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, received Food and Drug Administration (FDA) 510(k) clearance for its Dayspring® Lite treatment for lymphedema and venous disease. Unlike traditional compression pumps that require patients to be tethered to the wall during use,

MENLO PARK, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (NASDAQ: SGHT) today announced that it filed a lawsuit in the United States District Court in Delaware against Ivantis, Inc. for infringement of U.S. Patent Numbers 8,287,482, 9,370,443, 9,486,361, and 10,314,742. These patents describe and claim devices and methods for reducing intraocular pressure

NEW YORK, Sept. 9, 2021 /PRNewswire/ — Channel Medsystems, Inc. (“Channel” or “Company”) and InnovaHealth Partners, LP (“InnovaHealth”) jointly announced that InnovaHealth has made a growth equity investment in Channel and acquired a significant interest in the Company. Channel legacy investors, including Third Point, Longwood Fund, and GPG Ventures, also participated in the financing. The growth capital will support the

Sep 08, 2021, 09:00 ET Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology to Become Eirion’s Exclusive Botulinum API Manufacturer WOBURN, Mass. and JAVENÉ, France, Sept. 8, 2021 /PRNewswire/ Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnology solutions using hyaluronic acid and

MENLO PARK, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address the underlying causes of the world’s most prevalent eye diseases, today announced plans to participate in the upcoming virtual Morgan Stanley Global Healthcare Conference. Sight Sciences’ management